These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8196711)

  • 1. There are no neurophysiologic features characteristic of "axonal" Guillain-Barré syndrome.
    Cros D; Triggs WJ
    Muscle Nerve; 1994 Jun; 17(6):675-7. PubMed ID: 8196711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome: clinical neurophysiologic studies.
    Cros D; Triggs WJ
    Rev Neurol (Paris); 1996 May; 152(5):339-43. PubMed ID: 8881426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal damage in Guillain-Barré syndrome.
    van der Meché FG; Meulstee J; Kleyweg RP
    Muscle Nerve; 1991 Oct; 14(10):997-1002. PubMed ID: 1944413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor nerve inexcitability in Guillain-Barré syndrome. The spectrum of distal conduction block and axonal degeneration.
    Triggs WJ; Cros D; Gominak SC; Zuniga G; Beric A; Shahani BT; Ropper AH; Roongta SM
    Brain; 1992 Oct; 115 ( Pt 5)():1291-302. PubMed ID: 1422789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Hadden RD; Cornblath DR; Hughes RA; Zielasek J; Hartung HP; Toyka KV; Swan AV
    Ann Neurol; 1998 Nov; 44(5):780-8. PubMed ID: 9818934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute "axonal" Guillain-Barré syndrome in childhood.
    Reisin RC; Cersósimo R; García Alvarez M; Massaro M; Fejerman N
    Muscle Nerve; 1993 Dec; 16(12):1310-6. PubMed ID: 8232386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy.
    Van Asseldonk JT; Van den Berg LH; Kalmijn S; Wokke JH; Franssen H
    Brain; 2005 Apr; 128(Pt 4):880-91. PubMed ID: 15689367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conduction block in acute motor axonal neuropathy.
    Kokubun N; Nishibayashi M; Uncini A; Odaka M; Hirata K; Yuki N
    Brain; 2010 Oct; 133(10):2897-908. PubMed ID: 20855419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonal Guillain-Barré syndrome.
    Feasby TE
    Muscle Nerve; 1994 Jun; 17(6):678-9. PubMed ID: 8196712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor conduction studies in Guillain-Barré syndrome: description and prognostic value.
    Cornblath DR; Mellits ED; Griffin JW; McKhann GM; Albers JW; Miller RG; Feasby TE; Quaskey SA
    Ann Neurol; 1988 Apr; 23(4):354-9. PubMed ID: 3382170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sequential studies of motor nerve conduction in relation to the disease stages of Guillain-Barré syndrome].
    Kinoshita A; Kawamura J; Hashimoto S; Yamamoto T; Kubori T
    Rinsho Shinkeigaku; 1993 Jun; 33(6):600-5. PubMed ID: 8403678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Guillain-Barré syndrome: sorting out the pathological hallmark in an electrophysiological axonal case.
    Berciano J; García A; Villagrá NT; González F; Ramón C; Illa I; Berciano MT; Lafarga M
    J Peripher Nerv Syst; 2009 Mar; 14(1):54-63. PubMed ID: 19335540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal form of Guillain-Barré syndrome: evidence for macrophage-associated demyelination.
    Berciano J; Coria F; Montón F; Calleja J; Figols J; LaFarga M
    Muscle Nerve; 1993 Jul; 16(7):744-51. PubMed ID: 8505931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic evidence of severe distal nerve segment pathology in the Guillain-Barré syndrome.
    Miller RG; Peterson C; Rosenberg NL
    Muscle Nerve; 1987; 10(6):524-9. PubMed ID: 3627159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible conduction failure in pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.
    Capasso M; Notturno F; Manzoli C; Yuki N; Uncini A
    Muscle Nerve; 2010 Oct; 42(4):608-12. PubMed ID: 20878742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
    Kuwabara S; Yuki N; Koga M; Hattori T; Matsuura D; Miyake M; Noda M
    Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The refractory period of transmission is impaired in axonal Guillain-Barré syndrome.
    Kuwabara S; Bostock H; Ogawara K; Sung JY; Kanai K; Mori M; Hattori T; Burke D
    Muscle Nerve; 2003 Dec; 28(6):683-9. PubMed ID: 14639581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological changes in the acute "axonal" form of Guillain-Barre syndrome.
    Brown WF; Feasby TE; Hahn AF
    Muscle Nerve; 1993 Feb; 16(2):200-5. PubMed ID: 8429846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axonal conduction block at intermediate nerve segments in pure motor Guillain-Barré syndrome.
    Hong YH; Sung JJ; Oh MY; Moon HJ; Park KS; Lee KW
    J Peripher Nerv Syst; 2011 Mar; 16(1):37-46. PubMed ID: 21504501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies.
    Tankisi H; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
    Clin Neurophysiol; 2007 Nov; 118(11):2383-92. PubMed ID: 17900975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.